TrialInflammopharmacology2019

A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease.

Ingvar Bjarnason et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.